The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-1-(3,4-dihydroquinolin-1(2H)-yl)-2-(2-(methylamino)-1-phenylethoxy)ethan-1-one ID: ALA5272418
Max Phase: Preclinical
Molecular Formula: C20H24N2O2
Molecular Weight: 324.42
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNC[C@@H](OCC(=O)N1CCCc2ccccc21)c1ccccc1
Standard InChI: InChI=1S/C20H24N2O2/c1-21-14-19(17-9-3-2-4-10-17)24-15-20(23)22-13-7-11-16-8-5-6-12-18(16)22/h2-6,8-10,12,19,21H,7,11,13-15H2,1H3/t19-/m1/s1
Standard InChI Key: WJOYDVHWRQOERV-LJQANCHMSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
-2.8573 0.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1428 0.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4283 0.4122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4283 -0.4128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1428 -0.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8573 -0.4128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7163 -0.8245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7160 -1.6497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4260 -2.0618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1426 -1.6538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7140 0.8246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7140 1.6494 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0002 0.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7144 0.8246 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4288 0.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1430 0.8246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4288 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1430 -0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1422 -1.6474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4277 -2.0599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7162 -1.6509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7114 -0.8266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1430 1.6494 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8573 2.0618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 0
4 3 1 0
5 4 2 0
1 6 1 0
6 5 1 0
4 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
5 10 1 0
3 11 1 0
11 12 2 0
11 13 1 0
13 14 1 0
14 15 1 0
15 16 1 6
15 17 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
22 21 2 0
17 22 1 0
16 23 1 0
23 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 324.42Molecular Weight (Monoisotopic): 324.1838AlogP: 2.94#Rotatable Bonds: 6Polar Surface Area: 41.57Molecular Species: BASEHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.05CX LogP: 2.81CX LogD: 1.16Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.89Np Likeness Score: -0.67
References 1. Dickson L, Teall M, Chevalier E, Cheung T, Liwicki GM, Mack S, Stephenson A, White K, Fosbeary R, Harrison DC, Brice NL, Doyle K, Ciccocioppo R, Wu C, Almond S, Patel TR, Mitchell P, Barnes M, Ayscough AP, Dawson LA, Carlton M, Bürli RW.. (2023) Discovery of CVN636 : A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist., 14 (4): [PMID:37077399 ] [10.1021/acsmedchemlett.2c00529 ]